{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:50:46Z","timestamp":1793407846715,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.neuropharm.2013.06.002","type":"journal-article","created":{"date-parts":[[2013,6,15]],"date-time":"2013-06-15T03:16:40Z","timestamp":1371266200000},"page":"425-431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Seizure protection by intrapulmonary delivery of midazolam in mice"],"prefix":"10.1016","volume":"73","author":[{"given":"Ashish","family":"Dhir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Zolkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Rogawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2013.06.002_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejphar.2008.03.038","article-title":"Nitric oxide signaling pathway in the anti-convulsant effect of adenosine against pentylenetetrazol-induced seizure threshold in mice","volume":"587","author":"Akula","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"Suppl.","key":"10.1016\/j.neuropharm.2013.06.002_bib2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/0300-9572(88)90002-0","article-title":"Clinical pharmacology of Dormicum (midazolam) and Anexate (flumazenil)","volume":"16","author":"Amrein","year":"1988","journal-title":"Resuscitation"},{"key":"10.1016\/j.neuropharm.2013.06.002_bib3","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.addr.2012.01.017","article-title":"Current oral and non-oral routes of antiepileptic drug delivery","volume":"64","author":"Anderson","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.neuropharm.2013.06.002_bib4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1165\/ajrcmb.16.3.9070608","article-title":"Expression and localization of CYP3A4 and CYP3A5 in human lung","volume":"16","author":"Anttila","year":"1997","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.neuropharm.2013.06.002_bib5","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1124\/dmd.110.032227","article-title":"Contribution of rat pulmonary metabolism to the elimination of lidocaine, midazolam, and nifedipine","volume":"38","author":"Aoki","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.neuropharm.2013.06.002_bib6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/BF02439589","article-title":"Determinants of benzodiazepine brain uptake: lipophilicity versus binding affinity","volume":"93","author":"Arendt","year":"1987","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2013.06.002_bib7","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1526-4610.2009.01453.x","article-title":"A\u00a0randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine","volume":"49","author":"Aurora","year":"2009","journal-title":"Headache"},{"key":"10.1016\/j.neuropharm.2013.06.002_bib8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pediatrneurol.2005.09.006","article-title":"Intranasal midazolam vs rectal diazepam in acute childhood seizures","volume":"34","author":"Bhattacharyya","year":"2006","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.neuropharm.2013.06.002_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.toxlet.2005.07.002","article-title":"Effects of toluene on seizures induced by\u00a0convulsants acting at distinct ligand-gated ion channels","volume":"160","author":"Chan","year":"2006","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.neuropharm.2013.06.002_bib10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0091-3057(77)90036-3","article-title":"A\u00a0new device for the rapid measurement of impaired motor function in mice","volume":"6","author":"Coughenour","year":"1977","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2013.06.002_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0014-2999(01)01183-9","article-title":"Tolerance to the anticonvulsant activity of midazolam and allopregnanolone in a model of picrotoxin seizures","volume":"425","author":"Cz\u0142onkowska","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.06.002_bib12","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.pnpbp.2006.06.003","article-title":"Effect of cyclooxygenase inhibitors on pentylenetetrazol (PTZ)-induced convulsions: possible mechanism of action","volume":"30","author":"Dhir","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.06.002_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1124\/jpet.110.173591","article-title":"Seizure protection by intrapulmonary delivery of propofol hemisuccinate","volume":"336","author":"Dhir","year":"2010","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.06.002_bib14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev.pharmtox.43.100901.140251","article-title":"Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts","volume":"43","author":"Ding","year":"2003","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2013.06.002_bib15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/emj.4.3.169","article-title":"Midazolam: an effective intravenous agent for seizure control","volume":"4","author":"Galvin","year":"1987","journal-title":"Arch. Emerg. Med."},{"key":"10.1016\/j.neuropharm.2013.06.002_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/11209320-000000000-00000","article-title":"Oromucosal midazolam: a review of its use in pediatric patients with prolonged acute convulsive seizures","volume":"14","author":"Garnock-Jones","year":"2012","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.neuropharm.2013.06.002_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00204-002-0425-8","article-title":"Nasal midazolam as a novel anticonvulsive treatment against organophosphate-induced seizure activity in the guinea pig","volume":"77","author":"Gilat","year":"2003","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.neuropharm.2013.06.002_bib18","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/0006-2952(94)90543-6","article-title":"Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily","volume":"47","author":"Gorski","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.06.002_bib47","doi-asserted-by":"crossref","DOI":"10.1111\/ene.12091","article-title":"Phase IIa randomized double-blind, placebo-controlled study of inhaled apomorphine as acute challenge for rescuing \u2018off\u2019 periods in patients with established Parkinson's disease","author":"Grosset","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuropharm.2013.06.002_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.39.1.1","article-title":"Cytochrome P-450 3A4: regulation and role in drug metabolism","volume":"39","author":"Guengerich","year":"1999","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2013.06.002_bib20","first-page":"25","article-title":"The preclinical pharmacology of flumazenil","volume":"2","author":"Haefely","year":"1988","journal-title":"Eur. J. Anaesthesiol. Suppl."},{"key":"10.1016\/j.neuropharm.2013.06.002_bib21","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.pediatrneurol.2007.02.012","article-title":"Efficacy of intravenous midazolam for status epilepticus in childhood","volume":"36","author":"Hayashi","year":"2007","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.neuropharm.2013.06.002_bib22","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1124\/dmd.104.001313","article-title":"Evidence of significant contribution from CYP3A5 to hepatic drug metabolism","volume":"32","author":"Huang","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.neuropharm.2013.06.002_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00003246-199003000-00014","article-title":"Intravenous midazolam suppression on pentylenetetrazol-induced epileptogenic activity in a porcine model","volume":"18","author":"Jaimovich","year":"1990","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.neuropharm.2013.06.002_bib24","first-page":"816","article-title":"Brain uptake of benzodiazepines: effects of lipophilicity and plasma protein binding","volume":"245","author":"Jones","year":"1988","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.06.002_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neulet.2005.02.056","article-title":"Genetic deletion of the norepinephrine transporter decreases vulnerability to seizures","volume":"382","author":"Kaminski","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2013.06.002_bib48","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s40263-013-0075-9","article-title":"Loxapine inhalation powder: a review of its use in the acute treatment of agitation in patients with bipolar disorder or schizophrenia","volume":"27","author":"Keating","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2013.06.002_bib26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/01.anes.0000267503.85085.c0","article-title":"CNS 7056: a novel ultra-short-acting benzodiazepine","volume":"107","author":"Kilpatrick","year":"2007","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2013.06.002_bib27","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1111\/j.1528-1167.2007.01081.x","article-title":"Decreased efficacy of GABAA-receptor modulation by midazolam in the kainate model of temporal lobe epilepsy","volume":"48","author":"Liefaard","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2013.06.002_bib28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.toxlet.2005.04.003","article-title":"Cerebral and plasma kinetics of a high dose of midazolam and correlations with its respiratory effects in rats","volume":"159","author":"Megarbane","year":"2005","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.neuropharm.2013.06.002_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1600-0404.2010.01474.x","article-title":"Buccal midazolam or rectal diazepam for treatment of residential adult patients with serial seizures or status epilepticus","volume":"124","author":"Nakken","year":"2011","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neuropharm.2013.06.002_bib30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1248\/yakushi.123.369","article-title":"Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR","volume":"123","author":"Nishimura","year":"2003","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.neuropharm.2013.06.002_bib31","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0735-6757(94)90139-2","article-title":"Intravenous versus intramuscular midazolam in treatment of chemically induced generalized seizures in swine","volume":"12","author":"Orebaugh","year":"1994","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.neuropharm.2013.06.002_bib32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF01242464","article-title":"Spectrophotometric study of the acid-base equilibria of an imidazobenzodiazepine, midazolam, and its determination in pharmaceutical formulations","volume":"I","author":"Orive","year":"1989","journal-title":"Mikrochim. Acta [Wien]"},{"key":"10.1016\/j.neuropharm.2013.06.002_bib33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrd2153","article-title":"Inhaling medicines: delivering drugs to the body through the lungs","volume":"6","author":"Patton","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2013.06.002_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0169-409X(95)00113-L","article-title":"Mechanisms of macromolecule absorption by the lungs","volume":"19","author":"Patton","year":"1996","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.neuropharm.2013.06.002_bib35","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1513\/pats.200409-049TA","article-title":"The lungs as a portal of entry for systemic drug delivery","volume":"1","author":"Patton","year":"2004","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.neuropharm.2013.06.002_bib36","doi-asserted-by":"crossref","first-page":"17S","DOI":"10.1111\/j.1365-2125.1983.tb02267.x","article-title":"Preclinical pharmacology of midazolam","volume":"16","author":"Pieri","year":"1983","journal-title":"Brit. J. Clin. Pharmacol."},{"issue":"II","key":"10.1016\/j.neuropharm.2013.06.002_bib37","first-page":"2180","article-title":"Pharmacology of midazolam","volume":"31","author":"Pieri","year":"1981","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.neuropharm.2013.06.002_bib38","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1528-1157.1990.tb05381.x","article-title":"Comparison of midazolam and diazepam by the intramuscular route for the control of seizures in a mouse model of status epilepticus","volume":"31","author":"Raines","year":"1990","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2013.06.002_bib39","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00000542-198503000-00017","article-title":"Midazolam: pharmacology and uses","volume":"62","author":"Reves","year":"1985","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2013.06.002_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnpbp.2012.01.013","article-title":"Role of state-dependency in memory impairment induced by acute administration of midazolam in mice","volume":"37","author":"Sanday","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.06.002_bib41","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1093\/brain\/awr215","article-title":"The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol","volume":"134","author":"Shorvon","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2013.06.002_bib42","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMoa1107494","article-title":"Intramuscular versus intravenous therapy for prehospital status epilepticus","volume":"366","author":"Silbergleit","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2013.06.002_bib43","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/00498250500446208","article-title":"Comparative analysis of substrate and inhibitor interactions with CYP3A4 and CYP3A5","volume":"36","author":"Soars","year":"2006","journal-title":"Xenobiotica"},{"key":"10.1016\/j.neuropharm.2013.06.002_bib44","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0306-4522(90)90262-3","article-title":"Differential effects of antiepileptic drugs and \u03b2-carbolines on seizures induced by excitatory amino acids","volume":"39","author":"Turski","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.06.002_bib45","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.eplepsyres.2008.10.005","article-title":"A\u00a0pharmacokinetic and pharmacodynamic study, in healthy volunteers, of a rapidly absorbed intranasal midazolam formulation","volume":"83","author":"Wermeling","year":"2009","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2013.06.002_bib46","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1124\/dmd.30.8.883","article-title":"Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7","volume":"30","author":"Williams","year":"2002","journal-title":"Drug Metab. Dispos."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813002621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813002621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T07:52:52Z","timestamp":1539589972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390813002621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":48,"alternative-id":["S0028390813002621"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.06.002","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seizure protection by intrapulmonary delivery of midazolam in mice","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}